Related Experiment Videos
Lung cancer detection by a RT-nested PCR using MAGE A1--6 common primers
Sanghoon Jheon1, Dae-Sung Hyun, Sang-Chae Lee
1Department of Thoracic Surgery, Daegu Catholic Medical Center, Catholic University of Daegu, Daegu, South Korea.
Lung Cancer (Amsterdam, Netherlands)
|December 31, 2003
Summary
New research introduces a sensitive method for lung cancer detection using common melanoma antigen gene (MAGE) primers. This MAGE A1-6 RT-nested PCR assay shows high sensitivity and specificity in sputum samples, offering an effective tool for early lung cancer diagnosis.
Area of Science:
- Oncology
- Molecular Biology
- Diagnostic Medicine
Background:
- Lung cancer mortality remains high, necessitating sensitive detection methods.
- Common melanoma antigen genes (MAGE) A1-A6 are implicated in cancer development.
- Developing novel biomarkers for early lung cancer detection is crucial.
Purpose of the Study:
- To develop and evaluate a novel RT-nested PCR assay for simultaneous detection of MAGE A1-A6 subtypes.
- To assess the efficacy of the MAGE assay in detecting lung cancer using sputum specimens.
- To compare the diagnostic performance of the MAGE assay with existing methods like telomerase assay and cytology.
Main Methods:
- The study involved 53 cancer patients and 216 individuals from non-cancer groups (healthy, screening, benign lung disease).
- 136 respiratory specimens (sputa, BAL fluids, pleural fluids) from lung cancer patients were analyzed.
- MAGE A1-6 detection was performed using RT-nested PCR, with results compared to telomerase assay and cytology.
Main Results:
- The MAGE assay demonstrated low positive rates (<2.1%) in non-cancer groups.
- Detection rates were 83.3% in cancer tissues and 54.3% in lung cancer patient sputum.
- Induced sputum, BAL, and pleural fluids showed detection rates over 70.0%, outperforming telomerase assay and cytology.
Conclusions:
- MAGE A1-6 RT-nested PCR assay exhibits high sensitivity and specificity for lung cancer detection.
- This assay provides an effective and sensitive method for lung cancer diagnosis using sputum.
- The MAGE assay represents a promising advancement in non-invasive lung cancer diagnostics.